Review





Similar Products

96
Santa Cruz Biotechnology recombinant protein stemcell technologies 78031 paraformaldehyde solution
Recombinant Protein Stemcell Technologies 78031 Paraformaldehyde Solution, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/78031/pm41742404-174-43-53?v=Santa+Cruz+Biotechnology
Average 96 stars, based on 1 article reviews
recombinant protein stemcell technologies 78031 paraformaldehyde solution - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

92
BPS Bioscience ace2: spike s1 rbd, mouse fc-fusion (sars-cov-2) inhibitor screening colorimetric assay kit
Ace2: Spike S1 Rbd, Mouse Fc Fusion (Sars Cov 2) Inhibitor Screening Colorimetric Assay Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/78031/custom%4078031%4041484143?v=BPS+Bioscience
Average 92 stars, based on 1 article reviews
ace2: spike s1 rbd, mouse fc-fusion (sars-cov-2) inhibitor screening colorimetric assay kit - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc human recombinant il-2 #78031
Human Recombinant Il 2 #78031, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/78031/pm36309154-76-13-16?v=STEMCELL+Technologies+Inc
Average 90 stars, based on 1 article reviews
human recombinant il-2 #78031 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

92
BPS Bioscience mouse fc fusion
Mouse Fc Fusion, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/78031/pm36572420-83-5-18?v=BPS+Bioscience
Average 92 stars, based on 1 article reviews
mouse fc fusion - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

92
BPS Bioscience ace2 spike s1 rbd
Ace2 Spike S1 Rbd, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/78031/pm36572420-83-1-18?v=BPS+Bioscience
Average 92 stars, based on 1 article reviews
ace2 spike s1 rbd - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

92
BPS Bioscience enzyme 2 ace2 receptor inhibition activity
Effect of synthetized derivatives on <t> ACE2:SARS-CoV-2 </t> Spike (RBD) inhibition.
Enzyme 2 Ace2 Receptor Inhibition Activity, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/78031/pmc08403975-339-5-22?v=BPS+Bioscience
Average 92 stars, based on 1 article reviews
enzyme 2 ace2 receptor inhibition activity - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

92
BPS Bioscience ace2 sars cov 2 spike rbd inhibitor screening colorimetric assay kit
Effect of synthetized derivatives on <t> ACE2:SARS-CoV-2 </t> Spike (RBD) inhibition.
Ace2 Sars Cov 2 Spike Rbd Inhibitor Screening Colorimetric Assay Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/78031/pmc08403975-339-12-22?v=BPS+Bioscience
Average 92 stars, based on 1 article reviews
ace2 sars cov 2 spike rbd inhibitor screening colorimetric assay kit - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology aat1 shrna
( a ) Protein expression of <t>AAT1</t> and AAT2 in VSMCs transfected with 2 μg of AAT1, AAT2 or vehicle plasmid for 48 h. ( b ) Representative fluorescent staining (blue) of endogenous SO 2 in VSMCs transfected with AAT1, AAT2 or vehicle plasmid for 48 h. Scale bar, 20 μm. ( c ) SO 2 content in supernatant from VSMCs transfected with AAT1, AAT2 or vehicle plasmid for 48 h. ( d ) SO 2 content in supernatant from VSMCs transfected with AAT or vehicle plasmid was corrected with the number of cells (×10 4 ). ( e ) Collagen I (Col I) and III (Col III) expression in VSMCs by confocal images. VSMCs in coverslips were transfected with AAT1, AAT2 or vehicle before TGF-β1 (10 ng/ml) stimulation for 24 h. Scale bar, 20 μm. ( f ) Representative Western blot and quantification of collagen I and III in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment. *** P < 0.001 compared with vehicle, * P < 0.05 compared with vehicle, ### P < 0.001 or # P < 0.05 compared with vehicle + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).
Aat1 Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/78031/pmc04725894-163-29-61?v=Santa+Cruz+Biotechnology
Average 85 stars, based on 1 article reviews
aat1 shrna - by Bioz Stars, 2026-07
85/100 stars
  Buy from Supplier

94
R&D Systems rabbit anti erk1
( a ) Protein expression of <t>AAT1</t> and AAT2 in VSMCs transfected with 2 μg of AAT1, AAT2 or vehicle plasmid for 48 h. ( b ) Representative fluorescent staining (blue) of endogenous SO 2 in VSMCs transfected with AAT1, AAT2 or vehicle plasmid for 48 h. Scale bar, 20 μm. ( c ) SO 2 content in supernatant from VSMCs transfected with AAT1, AAT2 or vehicle plasmid for 48 h. ( d ) SO 2 content in supernatant from VSMCs transfected with AAT or vehicle plasmid was corrected with the number of cells (×10 4 ). ( e ) Collagen I (Col I) and III (Col III) expression in VSMCs by confocal images. VSMCs in coverslips were transfected with AAT1, AAT2 or vehicle before TGF-β1 (10 ng/ml) stimulation for 24 h. Scale bar, 20 μm. ( f ) Representative Western blot and quantification of collagen I and III in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment. *** P < 0.001 compared with vehicle, * P < 0.05 compared with vehicle, ### P < 0.001 or # P < 0.05 compared with vehicle + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).
Rabbit Anti Erk1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/78031/pmc04146698-92-5-9?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
rabbit anti erk1 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

Image Search Results


Effect of synthetized derivatives on  ACE2:SARS-CoV-2  Spike (RBD) inhibition.

Journal: Bioorganic Chemistry

Article Title: Synthesis of novel calcium channel blockers with ACE2 inhibition and dual antihypertensive/anti-inflammatory effects: A possible therapeutic tool for COVID-19

doi: 10.1016/j.bioorg.2021.105272

Figure Lengend Snippet: Effect of synthetized derivatives on ACE2:SARS-CoV-2 Spike (RBD) inhibition.

Article Snippet: In order to measure Angiotensin-Converting Enzyme 2 (ACE2) receptor inhibition activity, the ACE2:SARS-CoV-2 Spike (RBD) Inhibitor Screening Colorimetric Assay Kit # 78031 (Bps Bioscience, Cornerstone Court W, Ste B San Diego, CA 92121) was used.

Techniques: Inhibition

SAR for the most potent compounds. DHPMs: Dihydropyrimidines, CCBs: calcium channel blockers, ACE2: Angiotensin-converting enzyme 2, THP-1: Human monocytic cell line, IL-6: Interleukine-6, LPS: Lipopolysaccharide, CRP: C-Reactive Protein.

Journal: Bioorganic Chemistry

Article Title: Synthesis of novel calcium channel blockers with ACE2 inhibition and dual antihypertensive/anti-inflammatory effects: A possible therapeutic tool for COVID-19

doi: 10.1016/j.bioorg.2021.105272

Figure Lengend Snippet: SAR for the most potent compounds. DHPMs: Dihydropyrimidines, CCBs: calcium channel blockers, ACE2: Angiotensin-converting enzyme 2, THP-1: Human monocytic cell line, IL-6: Interleukine-6, LPS: Lipopolysaccharide, CRP: C-Reactive Protein.

Article Snippet: In order to measure Angiotensin-Converting Enzyme 2 (ACE2) receptor inhibition activity, the ACE2:SARS-CoV-2 Spike (RBD) Inhibitor Screening Colorimetric Assay Kit # 78031 (Bps Bioscience, Cornerstone Court W, Ste B San Diego, CA 92121) was used.

Techniques:

Effect of synthetized derivatives on  ACE2:SARS-CoV-2  Spike (RBD) inhibition.

Journal: Bioorganic Chemistry

Article Title: Synthesis of novel calcium channel blockers with ACE2 inhibition and dual antihypertensive/anti-inflammatory effects: A possible therapeutic tool for COVID-19

doi: 10.1016/j.bioorg.2021.105272

Figure Lengend Snippet: Effect of synthetized derivatives on ACE2:SARS-CoV-2 Spike (RBD) inhibition.

Article Snippet: In order to measure Angiotensin-Converting Enzyme 2 (ACE2) receptor inhibition activity, the ACE2:SARS-CoV-2 Spike (RBD) Inhibitor Screening Colorimetric Assay Kit # 78031 (Bps Bioscience, Cornerstone Court W, Ste B San Diego, CA 92121) was used.

Techniques: Inhibition

SAR for the most potent compounds. DHPMs: Dihydropyrimidines, CCBs: calcium channel blockers, ACE2: Angiotensin-converting enzyme 2, THP-1: Human monocytic cell line, IL-6: Interleukine-6, LPS: Lipopolysaccharide, CRP: C-Reactive Protein.

Journal: Bioorganic Chemistry

Article Title: Synthesis of novel calcium channel blockers with ACE2 inhibition and dual antihypertensive/anti-inflammatory effects: A possible therapeutic tool for COVID-19

doi: 10.1016/j.bioorg.2021.105272

Figure Lengend Snippet: SAR for the most potent compounds. DHPMs: Dihydropyrimidines, CCBs: calcium channel blockers, ACE2: Angiotensin-converting enzyme 2, THP-1: Human monocytic cell line, IL-6: Interleukine-6, LPS: Lipopolysaccharide, CRP: C-Reactive Protein.

Article Snippet: In order to measure Angiotensin-Converting Enzyme 2 (ACE2) receptor inhibition activity, the ACE2:SARS-CoV-2 Spike (RBD) Inhibitor Screening Colorimetric Assay Kit # 78031 (Bps Bioscience, Cornerstone Court W, Ste B San Diego, CA 92121) was used.

Techniques:

( a ) Protein expression of AAT1 and AAT2 in VSMCs transfected with 2 μg of AAT1, AAT2 or vehicle plasmid for 48 h. ( b ) Representative fluorescent staining (blue) of endogenous SO 2 in VSMCs transfected with AAT1, AAT2 or vehicle plasmid for 48 h. Scale bar, 20 μm. ( c ) SO 2 content in supernatant from VSMCs transfected with AAT1, AAT2 or vehicle plasmid for 48 h. ( d ) SO 2 content in supernatant from VSMCs transfected with AAT or vehicle plasmid was corrected with the number of cells (×10 4 ). ( e ) Collagen I (Col I) and III (Col III) expression in VSMCs by confocal images. VSMCs in coverslips were transfected with AAT1, AAT2 or vehicle before TGF-β1 (10 ng/ml) stimulation for 24 h. Scale bar, 20 μm. ( f ) Representative Western blot and quantification of collagen I and III in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment. *** P < 0.001 compared with vehicle, * P < 0.05 compared with vehicle, ### P < 0.001 or # P < 0.05 compared with vehicle + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).

Journal: Scientific Reports

Article Title: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells

doi: 10.1038/srep19503

Figure Lengend Snippet: ( a ) Protein expression of AAT1 and AAT2 in VSMCs transfected with 2 μg of AAT1, AAT2 or vehicle plasmid for 48 h. ( b ) Representative fluorescent staining (blue) of endogenous SO 2 in VSMCs transfected with AAT1, AAT2 or vehicle plasmid for 48 h. Scale bar, 20 μm. ( c ) SO 2 content in supernatant from VSMCs transfected with AAT1, AAT2 or vehicle plasmid for 48 h. ( d ) SO 2 content in supernatant from VSMCs transfected with AAT or vehicle plasmid was corrected with the number of cells (×10 4 ). ( e ) Collagen I (Col I) and III (Col III) expression in VSMCs by confocal images. VSMCs in coverslips were transfected with AAT1, AAT2 or vehicle before TGF-β1 (10 ng/ml) stimulation for 24 h. Scale bar, 20 μm. ( f ) Representative Western blot and quantification of collagen I and III in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment. *** P < 0.001 compared with vehicle, * P < 0.05 compared with vehicle, ### P < 0.001 or # P < 0.05 compared with vehicle + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).

Article Snippet: After 24 h, they were starved in DMEM with 0.5% FBS before TGF-β1 (10 ng/ml) treatment for 1 h. In the second series, cells were transfected with control shRNA, AAT1 shRNA or AAT2 shRNA for 24 h. Then they were starved for 24 h followed by TGF-β1 treatment for 1 h. The cells were then harvested with the antibody against TβRI (Santa Cruz Biotechnology, catalog sc-398) before immunoprecipitation with protein A/G agarose beads (Thermo Fisher Scientific, Waltham, MA, USA) .

Techniques: Expressing, Transfection, Plasmid Preparation, Staining, Western Blot

( a ) Protein expression of AAT1 and AAT2 in VSMCs transfected with 2 μg of control shRNA (sh-Con), AAT1 shRNA (sh-AAT1) or AAT2 shRNA (sh-AAT2) for 48 h. ( b ) Representative fluorescent staining (blue) of endogenous SO 2 in VSMCs transfected with Con, AAT1 or AAT2 shRNA for 48 h. Scale bar, 20 μm. ( c ) SO 2 content in supernatant from VSMCs transfected with Con, AAT1 or AAT2 shRNA for 48 h. ( d ) Collagen I and III expression in VSMCs by confocal images. VSMCs in coverslips were transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 (10 ng/ml) stimulation for 24 h. Scale bar, 20 μm. ( e ) Representative Western blot and quantification of collagen I and III in VSMCs transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment. *** P < 0.001, ** P < 0.01 or * P < 0.05 compared with Con shRNA, ## P < 0.01 or # P < 0.05 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Journal: Scientific Reports

Article Title: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells

doi: 10.1038/srep19503

Figure Lengend Snippet: ( a ) Protein expression of AAT1 and AAT2 in VSMCs transfected with 2 μg of control shRNA (sh-Con), AAT1 shRNA (sh-AAT1) or AAT2 shRNA (sh-AAT2) for 48 h. ( b ) Representative fluorescent staining (blue) of endogenous SO 2 in VSMCs transfected with Con, AAT1 or AAT2 shRNA for 48 h. Scale bar, 20 μm. ( c ) SO 2 content in supernatant from VSMCs transfected with Con, AAT1 or AAT2 shRNA for 48 h. ( d ) Collagen I and III expression in VSMCs by confocal images. VSMCs in coverslips were transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 (10 ng/ml) stimulation for 24 h. Scale bar, 20 μm. ( e ) Representative Western blot and quantification of collagen I and III in VSMCs transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment. *** P < 0.001, ** P < 0.01 or * P < 0.05 compared with Con shRNA, ## P < 0.01 or # P < 0.05 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Article Snippet: After 24 h, they were starved in DMEM with 0.5% FBS before TGF-β1 (10 ng/ml) treatment for 1 h. In the second series, cells were transfected with control shRNA, AAT1 shRNA or AAT2 shRNA for 24 h. Then they were starved for 24 h followed by TGF-β1 treatment for 1 h. The cells were then harvested with the antibody against TβRI (Santa Cruz Biotechnology, catalog sc-398) before immunoprecipitation with protein A/G agarose beads (Thermo Fisher Scientific, Waltham, MA, USA) .

Techniques: Expressing, Transfection, Control, shRNA, Staining, Western Blot

( a,b ) Procollagen I ( a ) and III ( b ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 24 h. *** P < 0.001 compared with vehicle, ### P < 0.001 compared with vehicle + TGF-β1 group (ANOVA). ( c,d ) Procollagen I ( c ) and III ( d ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 24 h. *** P < 0.001 compared with Con shRNA, ### P < 0.001 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Journal: Scientific Reports

Article Title: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells

doi: 10.1038/srep19503

Figure Lengend Snippet: ( a,b ) Procollagen I ( a ) and III ( b ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 24 h. *** P < 0.001 compared with vehicle, ### P < 0.001 compared with vehicle + TGF-β1 group (ANOVA). ( c,d ) Procollagen I ( c ) and III ( d ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 24 h. *** P < 0.001 compared with Con shRNA, ### P < 0.001 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Article Snippet: After 24 h, they were starved in DMEM with 0.5% FBS before TGF-β1 (10 ng/ml) treatment for 1 h. In the second series, cells were transfected with control shRNA, AAT1 shRNA or AAT2 shRNA for 24 h. Then they were starved for 24 h followed by TGF-β1 treatment for 1 h. The cells were then harvested with the antibody against TβRI (Santa Cruz Biotechnology, catalog sc-398) before immunoprecipitation with protein A/G agarose beads (Thermo Fisher Scientific, Waltham, MA, USA) .

Techniques: Expressing, Real-time Polymerase Chain Reaction, Transfection, Plasmid Preparation, shRNA

( a,b ) MMP-13 ( a ) and TIMP-1 ( b ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 24 h. * P < 0.05 or *** P < 0.001 compared with vehicle, ### P < 0.001 compared with vehicle + TGF-β1 group (ANOVA). ( c ) Representative Western blot and quantification of MMP-13 and TIMP-1 in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 24 h. *** P < 0.001 compared with vehicle, ### P < 0.001 or ## P < 0.01 compared with vehicle + TGF-β1 group (ANOVA). ( d,e ) MMP-13 ( d ) and TIMP-1 ( e ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 24 h. *** P < 0.001 compared with vehicle, # P < 0.05, ## P < 0.01 or ### P < 0.001 compared with Con shRNA + TGF-β1 group (ANOVA). ( f ) Representative Western blot and quantification of MMP-13 and TIMP-1 in VSMCs transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 24 h. *** P < 0.001 or * P < 0.05 compared with Con shRNA, ### P < 0.001 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Journal: Scientific Reports

Article Title: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells

doi: 10.1038/srep19503

Figure Lengend Snippet: ( a,b ) MMP-13 ( a ) and TIMP-1 ( b ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 24 h. * P < 0.05 or *** P < 0.001 compared with vehicle, ### P < 0.001 compared with vehicle + TGF-β1 group (ANOVA). ( c ) Representative Western blot and quantification of MMP-13 and TIMP-1 in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 24 h. *** P < 0.001 compared with vehicle, ### P < 0.001 or ## P < 0.01 compared with vehicle + TGF-β1 group (ANOVA). ( d,e ) MMP-13 ( d ) and TIMP-1 ( e ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 24 h. *** P < 0.001 compared with vehicle, # P < 0.05, ## P < 0.01 or ### P < 0.001 compared with Con shRNA + TGF-β1 group (ANOVA). ( f ) Representative Western blot and quantification of MMP-13 and TIMP-1 in VSMCs transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 24 h. *** P < 0.001 or * P < 0.05 compared with Con shRNA, ### P < 0.001 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Article Snippet: After 24 h, they were starved in DMEM with 0.5% FBS before TGF-β1 (10 ng/ml) treatment for 1 h. In the second series, cells were transfected with control shRNA, AAT1 shRNA or AAT2 shRNA for 24 h. Then they were starved for 24 h followed by TGF-β1 treatment for 1 h. The cells were then harvested with the antibody against TβRI (Santa Cruz Biotechnology, catalog sc-398) before immunoprecipitation with protein A/G agarose beads (Thermo Fisher Scientific, Waltham, MA, USA) .

Techniques: Expressing, Real-time Polymerase Chain Reaction, Transfection, Plasmid Preparation, Western Blot, shRNA

( a ) p-Smad2 and p-Smad3 protein expression in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 1 h. *** P < 0.001 compared with vehicle, ### P < 0.001 compared with vehicle + TGF-β1 group (ANOVA). ( b ) PAI-1 mRNA expression in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 stimulation for 8 h. * P < 0.05 compared with vehicle, # P < 0.05 compared with vehicle + TGF-β1 group (ANOVA). ( c ) p-Smad2 and p-Smad3 protein expression in VSMCs transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 1 h. *** P < 0.001 compared with Con shRNA, ### P < 0.001 or ## P < 0.01 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).

Journal: Scientific Reports

Article Title: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells

doi: 10.1038/srep19503

Figure Lengend Snippet: ( a ) p-Smad2 and p-Smad3 protein expression in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 1 h. *** P < 0.001 compared with vehicle, ### P < 0.001 compared with vehicle + TGF-β1 group (ANOVA). ( b ) PAI-1 mRNA expression in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 stimulation for 8 h. * P < 0.05 compared with vehicle, # P < 0.05 compared with vehicle + TGF-β1 group (ANOVA). ( c ) p-Smad2 and p-Smad3 protein expression in VSMCs transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 1 h. *** P < 0.001 compared with Con shRNA, ### P < 0.001 or ## P < 0.01 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).

Article Snippet: After 24 h, they were starved in DMEM with 0.5% FBS before TGF-β1 (10 ng/ml) treatment for 1 h. In the second series, cells were transfected with control shRNA, AAT1 shRNA or AAT2 shRNA for 24 h. Then they were starved for 24 h followed by TGF-β1 treatment for 1 h. The cells were then harvested with the antibody against TβRI (Santa Cruz Biotechnology, catalog sc-398) before immunoprecipitation with protein A/G agarose beads (Thermo Fisher Scientific, Waltham, MA, USA) .

Techniques: Expressing, Transfection, Plasmid Preparation, shRNA

( a ) p-TβRI and TβRI protein expression in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 1 h. *** P < 0.001 compared with vehicle, ### P < 0.001 compared with vehicle + TGF-β1 group (ANOVA). ( b ) p-TβRI and TβRI protein expression in VSMCs transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 1 h. *** P < 0.001 compared with Con shRNA, ### P < 0.001 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Journal: Scientific Reports

Article Title: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells

doi: 10.1038/srep19503

Figure Lengend Snippet: ( a ) p-TβRI and TβRI protein expression in VSMCs transfected with AAT1, AAT2 or vehicle plasmid before TGF-β1 treatment for 1 h. *** P < 0.001 compared with vehicle, ### P < 0.001 compared with vehicle + TGF-β1 group (ANOVA). ( b ) p-TβRI and TβRI protein expression in VSMCs transfected with Con, AAT1 or AAT2 shRNA before TGF-β1 treatment for 1 h. *** P < 0.001 compared with Con shRNA, ### P < 0.001 compared with Con shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Article Snippet: After 24 h, they were starved in DMEM with 0.5% FBS before TGF-β1 (10 ng/ml) treatment for 1 h. In the second series, cells were transfected with control shRNA, AAT1 shRNA or AAT2 shRNA for 24 h. Then they were starved for 24 h followed by TGF-β1 treatment for 1 h. The cells were then harvested with the antibody against TβRI (Santa Cruz Biotechnology, catalog sc-398) before immunoprecipitation with protein A/G agarose beads (Thermo Fisher Scientific, Waltham, MA, USA) .

Techniques: Expressing, Transfection, Plasmid Preparation, shRNA

( a,b ) Procollagen I ( a ) and III ( b ) mRNA expression in VSMCs by real-time PCR. VSMCs transfected with Con, AAT1 or AAT2 shRNA were pretreated with SB431542 (5 μmol/L) for 1 h, and then stimulated with TGF-β1 for 24 h. ( c ) Collagen I and III expression in VSMCs by confocal images. VSMCs in coverslips transfected with Con, AAT1 or AAT2 shRNA were pretreated with SB431542 (5 μmol/L) for 1 h, and then stimulated with TGF-β1 for 24 h. Scale bar, 20 μm. ( d ) Representative Western blot and quantification of collagen I and III in VSMCs. VSMCs transfected with Con, AAT1 or AAT2 shRNA were pretreated with SB431542 (5 μmol/L) for 1 h, and then stimulated with TGF-β1 for 24 h. *** P < 0.001 or * P < 0.05 compared with Con shRNA, ### P < 0.001, ## P < 0.01 or # P < 0.05 compared with Con shRNA + TGF-β1 group, &&& P < 0.001 compared with AAT1 shRNA + TGF-β1 group, and +++ P < 0.001 compared with AAT2 shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Journal: Scientific Reports

Article Title: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells

doi: 10.1038/srep19503

Figure Lengend Snippet: ( a,b ) Procollagen I ( a ) and III ( b ) mRNA expression in VSMCs by real-time PCR. VSMCs transfected with Con, AAT1 or AAT2 shRNA were pretreated with SB431542 (5 μmol/L) for 1 h, and then stimulated with TGF-β1 for 24 h. ( c ) Collagen I and III expression in VSMCs by confocal images. VSMCs in coverslips transfected with Con, AAT1 or AAT2 shRNA were pretreated with SB431542 (5 μmol/L) for 1 h, and then stimulated with TGF-β1 for 24 h. Scale bar, 20 μm. ( d ) Representative Western blot and quantification of collagen I and III in VSMCs. VSMCs transfected with Con, AAT1 or AAT2 shRNA were pretreated with SB431542 (5 μmol/L) for 1 h, and then stimulated with TGF-β1 for 24 h. *** P < 0.001 or * P < 0.05 compared with Con shRNA, ### P < 0.001, ## P < 0.01 or # P < 0.05 compared with Con shRNA + TGF-β1 group, &&& P < 0.001 compared with AAT1 shRNA + TGF-β1 group, and +++ P < 0.001 compared with AAT2 shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 5).

Article Snippet: After 24 h, they were starved in DMEM with 0.5% FBS before TGF-β1 (10 ng/ml) treatment for 1 h. In the second series, cells were transfected with control shRNA, AAT1 shRNA or AAT2 shRNA for 24 h. Then they were starved for 24 h followed by TGF-β1 treatment for 1 h. The cells were then harvested with the antibody against TβRI (Santa Cruz Biotechnology, catalog sc-398) before immunoprecipitation with protein A/G agarose beads (Thermo Fisher Scientific, Waltham, MA, USA) .

Techniques: Expressing, Real-time Polymerase Chain Reaction, Transfection, shRNA, Western Blot

( a ) Representative Western blot and quantification of AAT1, AAT2, collagen I and III in VSMCs. VSMCs were co-transfected with Con shRNA and vehicle, AAT1 shRNA and vehicle, AAT2 shRNA and vehicle, AAT1 shRNA and AAT1, or AAT2 shRNA and AAT2 for 48 h, and then stimulated with TGF-β1 for 24 h. ( b ) SO 2 level in cell supernatant detected by HPLC-FD. ( c,d ) Procollagen I ( c ) and III ( d ) mRNA expression in VSMCs by real-time PCR. VSMCs were co-transfected with Con shRNA and vehicle, AAT1 shRNA and vehicle, AAT2 shRNA and vehicle, AAT1 shRNA and AAT1, or AAT2 shRNA and AAT2 for 48 h, and then stimulated with TGF-β1 for 24 h. * P < 0.05 compared with Con shRNA + vehicle, # P < 0.05 compared with Con shRNA + vehicle + TGF-β1 group, & P < 0.05 compared with AAT1 shRNA + vehicle + TGF-β1 group, and + P < 0.05 compared with AAT2 shRNA + vehicle + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).

Journal: Scientific Reports

Article Title: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells

doi: 10.1038/srep19503

Figure Lengend Snippet: ( a ) Representative Western blot and quantification of AAT1, AAT2, collagen I and III in VSMCs. VSMCs were co-transfected with Con shRNA and vehicle, AAT1 shRNA and vehicle, AAT2 shRNA and vehicle, AAT1 shRNA and AAT1, or AAT2 shRNA and AAT2 for 48 h, and then stimulated with TGF-β1 for 24 h. ( b ) SO 2 level in cell supernatant detected by HPLC-FD. ( c,d ) Procollagen I ( c ) and III ( d ) mRNA expression in VSMCs by real-time PCR. VSMCs were co-transfected with Con shRNA and vehicle, AAT1 shRNA and vehicle, AAT2 shRNA and vehicle, AAT1 shRNA and AAT1, or AAT2 shRNA and AAT2 for 48 h, and then stimulated with TGF-β1 for 24 h. * P < 0.05 compared with Con shRNA + vehicle, # P < 0.05 compared with Con shRNA + vehicle + TGF-β1 group, & P < 0.05 compared with AAT1 shRNA + vehicle + TGF-β1 group, and + P < 0.05 compared with AAT2 shRNA + vehicle + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).

Article Snippet: After 24 h, they were starved in DMEM with 0.5% FBS before TGF-β1 (10 ng/ml) treatment for 1 h. In the second series, cells were transfected with control shRNA, AAT1 shRNA or AAT2 shRNA for 24 h. Then they were starved for 24 h followed by TGF-β1 treatment for 1 h. The cells were then harvested with the antibody against TβRI (Santa Cruz Biotechnology, catalog sc-398) before immunoprecipitation with protein A/G agarose beads (Thermo Fisher Scientific, Waltham, MA, USA) .

Techniques: Western Blot, Transfection, shRNA, Expressing, Real-time Polymerase Chain Reaction

( a ) Representative Western blot and quantification of AAT1, AAT2, collagen I and III in VSMCs. VSMCs were transfected with Con shRNA, AAT1 shRNA or AAT2 shRNA for 48 h, pretreated with SO 2 derivatives (NaHSO 3 /Na 2 SO 3 , 100 μM) or ethyl pyruvate (EP, 100 μM) for 1 h, and then stimulated with TGF-β1 for 24 h. ( b ) SO 2 level in cell supernatant detected by HPLC-FD. ( c,d ) Procollagen I ( c ) and III ( d ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with Con shRNA, AAT1 shRNA or AAT2 shRNA for 48 h, pretreated with SO 2 derivatives (NaHSO 3 /Na 2 SO 3 , 100 μM) or ethyl pyruvate (EP, 100 μM) for 1 h, and then stimulated with TGF-β1 for 24 h. * P < 0.05 compared with Con shRNA, # P < 0.05 compared with Con shRNA + TGF-β1 group, & P < 0.05 compared with AAT1 shRNA + TGF-β1 group, and + P < 0.05 compared with AAT2 shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).

Journal: Scientific Reports

Article Title: Endogenous sulfur dioxide alleviates collagen remodeling via inhibiting TGF-β/Smad pathway in vascular smooth muscle cells

doi: 10.1038/srep19503

Figure Lengend Snippet: ( a ) Representative Western blot and quantification of AAT1, AAT2, collagen I and III in VSMCs. VSMCs were transfected with Con shRNA, AAT1 shRNA or AAT2 shRNA for 48 h, pretreated with SO 2 derivatives (NaHSO 3 /Na 2 SO 3 , 100 μM) or ethyl pyruvate (EP, 100 μM) for 1 h, and then stimulated with TGF-β1 for 24 h. ( b ) SO 2 level in cell supernatant detected by HPLC-FD. ( c,d ) Procollagen I ( c ) and III ( d ) mRNA expression in VSMCs by real-time PCR. VSMCs were transfected with Con shRNA, AAT1 shRNA or AAT2 shRNA for 48 h, pretreated with SO 2 derivatives (NaHSO 3 /Na 2 SO 3 , 100 μM) or ethyl pyruvate (EP, 100 μM) for 1 h, and then stimulated with TGF-β1 for 24 h. * P < 0.05 compared with Con shRNA, # P < 0.05 compared with Con shRNA + TGF-β1 group, & P < 0.05 compared with AAT1 shRNA + TGF-β1 group, and + P < 0.05 compared with AAT2 shRNA + TGF-β1 group (ANOVA). Data are represented as mean ± SD (n = 4–5).

Article Snippet: After 24 h, they were starved in DMEM with 0.5% FBS before TGF-β1 (10 ng/ml) treatment for 1 h. In the second series, cells were transfected with control shRNA, AAT1 shRNA or AAT2 shRNA for 24 h. Then they were starved for 24 h followed by TGF-β1 treatment for 1 h. The cells were then harvested with the antibody against TβRI (Santa Cruz Biotechnology, catalog sc-398) before immunoprecipitation with protein A/G agarose beads (Thermo Fisher Scientific, Waltham, MA, USA) .

Techniques: Western Blot, Transfection, shRNA, Expressing, Real-time Polymerase Chain Reaction